Seres Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Seres Therapeutics, Inc. (MCRB) had Operating Lease, Weighted Average Discount Rate, Percent of 11.40% as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 11.40%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 13.00%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 13.00%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 13.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 11.40% 10-Q · filed 2026-08-05 |
| 2026-03-31 | 13.00% 10-Q · filed 2026-05-05 |
| 2025-12-31 | 13.00% 10-K · filed 2026-03-12 |
| 2025-09-30 | 13.00% 10-Q · filed 2025-11-05 |
| 2025-06-30 | 13.00% 10-Q · filed 2026-08-05 |
| 2025-03-31 | 13.00% 10-Q · filed 2026-05-05 |
| 2024-12-31 | 13.00% 10-K · filed 2026-03-12 |
| 2024-09-30 | 13.00% 10-Q · filed 2025-11-05 |
| 2024-06-30 | 13.00% 10-Q · filed 2025-08-06 |
| 2024-03-31 | 13.00% 10-Q · filed 2025-05-07 |
| 2023-12-31 | 13.00% 10-K · filed 2025-03-13 |
| 2023-09-30 | 13.00% 10-Q · filed 2023-11-02 |
| 2023-06-30 | 13.00% 10-Q · filed 2024-08-13 |
| 2023-03-31 | 13.00% 10-Q · filed 2024-05-08 |
| 2022-12-31 | 13.00% 8-K · filed 2024-08-15 |
| 2022-09-30 | 10.00% 10-Q · filed 2023-11-02 |
| 2022-06-30 | 10.00% 10-Q · filed 2023-08-08 |
| 2022-03-31 | 10.00% 10-Q · filed 2023-05-09 |
| 2021-12-31 | 10.00% 10-K · filed 2023-03-07 |
| 2021-09-30 | 10.00% 10-Q · filed 2022-11-02 |
| 2021-06-30 | 10.00% 10-Q · filed 2022-08-03 |
| 2021-03-31 | 11.00% 10-Q · filed 2022-05-04 |
| 2020-12-31 | 11.00% 10-K · filed 2022-03-01 |
| 2019-12-31 | 11.00% 10-K · filed 2021-03-02 |
| 2019-09-30 | 11.00% 10-Q · filed 2019-11-05 |
| 2019-06-30 | 11.00% 10-Q · filed 2019-08-06 |
| 2019-03-31 | 11.00% 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |